Estrogen receptor dependent gene expression by osteoblasts - Direct, indirect, circumspect, and speculative effects

Steroids

Volumn 77, Issue 3, 2012, Pages 174-184

  Centrella, Michael ^a   McCarthy, Thomas L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differential gene expression; Estrogen receptors; Growth factors; Hormones; Steroid synthesis and metabolism; Transcription factors

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GROWTH FACTOR; SOMATOMEDIN C; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

BONE GROWTH; BONE REMODELING; FEMALE GENITAL SYSTEM; GENE EXPRESSION; HUMAN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; RECEPTOR UPREGULATION; REVIEW;

ANIMALS; CELL DIFFERENTIATION; ESTRADIOL; GENE EXPRESSION; HUMANS; LIGANDS; OSTEOBLASTS; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, ESTROGEN; RECEPTORS, SOMATOMEDIN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SOMATOMEDINS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; WNT SIGNALING PATHWAY;

EID: 84855899371     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.10.016     Document Type: Review

References (226)

1. A. Maggi Liganded and unliganded activation of estrogen receptor and hormone replacement therapies Biochim Biophys Acta 1812 2011 1054 1060
2. N.F. Col, L.A. Bowlby, and K. McGarry The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence Minerva Med 96 2005 331 342 (Pubitemid 41745593)
3. J.L. Turgeon, M.C. Carr, P.M. Maki, M.E. Mendelsohn, and P.M. Wise Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies Endocr Rev 27 2006 575 605 (Pubitemid 44582052)
4. D.W. Brann, K. Dhandapani, C. Wakade, V.B. Mahesh, and M.M. Khan Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications Steroids 72 2007 381 405 (Pubitemid 46602478)
5. X.P. Yang, and J.F. Reckelhoff Estrogen, hormonal replacement therapy and cardiovascular disease Curr Opin Nephrol Hypertens 20 2011 133 138
6. M.M. Grumbach, and R.J. Auchus Estrogen: consequences and implications of human mutations in synthesis and action J Clin Endocrinol Metab 84 1999 4677 4694
7. B.C. van der Eerden, M. Karperien, and J.M. Wit The estrogen receptor in the growth plate: implications for pubertal growth J Pediatr Endocrinol Metab 14 Suppl. 6 2001 1527 1533 (Pubitemid 33730769)
8. M.E. Wierman Sex steroid effects at target tissues: mechanisms of action Adv Physiol Educ 31 2007 26 33
9. A.C. Pike Lessons learnt from structural studies of the oestrogen receptor Best Pract Res Clin Endocrinol Metab 20 2006 1 14 (Pubitemid 43328570)
10. R.D. Ward, and N.L. Weigel Steroid receptor phosphorylation: assigning function to site-specific phosphorylation Biofactors 35 2009 528 536
11. S. Sentis, M. Le Romancer, C. Bianchin, M.C. Rostan, and L. Corbo Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity Mol Endocrinol 19 2005 2671 2684 (Pubitemid 41577242)
12. Y. Cui, M. Zhang, R. Pestell, E.M. Curran, W.V. Welshons, and S.A. Fuqua Phosphorylation of estrogen receptor alpha blocks its acetylation and regulates estrogen sensitivity Cancer Res 64 2004 9199 9208 (Pubitemid 39665536)
13. M.Y. Kim, E.M. Woo, Y.T. Chong, D.R. Homenko, and W.L. Kraus Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor Mol Endocrinol 20 2006 1479 1493 (Pubitemid 43967558)
14. C. Wang, M. Fu, R.H. Angeletti, L. Siconolfi-Baez, A.T. Reutens, and C. Albanese Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity J Biol Chem 276 2001 18375 18383
15. Q. Zhou, P.G. Shaw, and N.E. Davidson Epigenetics meets estrogen receptor: regulation of estrogen receptor by direct lysine methylation Endocr Relat Cancer 16 2009 319 323
16. C. Teyssier, M. Le Romancer, S. Sentis, S. Jalaguier, L. Corbo, and V. Cavailles Protein arginine methylation in estrogen signaling and estrogen-related cancers Trends Endocrinol Metab 21 2010 181 189
17. M. Marino, P. Ascenzi, and F. Acconcia S-Palmitoylation modulates estrogen receptor alpha localization and functions Steroids 71 2006 298 303
18. Q.X. Zhang, A. Borg, D.M. Wolf, S. Oesterreich, and S.A. Fuqua An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer Cancer Res 57 1997 1244 1249 (Pubitemid 27152545)
19. I. Barone, L. Brusco, and S.A. Fuqua Estrogen receptor mutations and changes in downstream gene expression and signaling Clin Cancer Res 16 2010 2702 2708
20. E.K. Shanle, and W. Xu Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action Chem Res Toxicol 24 2011 6 19
21. K.A. Burns, Y. Li, Y. Arao, R.M. Petrovich, and K.S. Korach Selective mutations in estrogen receptor alpha D-domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms J Biol Chem 286 2011 12640 12649
22. W. Zwart, R. de Leeuw, M. Rondaij, J. Neefjes, M.A. Mancini, and R. Michalides The hinge region of the human estrogen receptor determines functional synergy between AF-1 and AF-2 in the quantitative response to estradiol and tamoxifen J Cell Sci 123 2010 1253 1261
23. D.F. Skafar, and C. Zhao The multifunctional estrogen receptor-alpha F domain Endocrine 33 2008 1 8
24. E.H. Kong, A.C. Pike, and R.E. Hubbard Structure and mechanism of the oestrogen receptor Biochem Soc Trans 31 2003 56 59 (Pubitemid 36244928)
25. D.C. Leitman, S. Paruthiyil, O.I. Vivar, E.F. Saunier, C.B. Herber, and I. Cohen Regulation of specific target genes and biological responses by estrogen receptor subtype agonists Curr Opin Pharmacol 10 2010 629 636
26. Cato AC, Nestl A, Mink S. Rapid actions of steroid receptors in cellular signaling pathways. Sci STKE 2002:RE9.
27. V. Rudnik, A. Sanyal, F.A. Syed, D.G. Monroe, T.C. Spelsberg, and M.J. Oursler Loss of ERE binding activity by estrogen receptor-alpha alters basal and estrogen-stimulated bone-related gene expression by osteoblastic cells J Cell Biochem 103 2008 896 907 (Pubitemid 351240625)
28. J.S. Carroll, and M. Brown Estrogen receptor target gene: an evolving concept Mol Endocrinol 20 2006 1707 1714 (Pubitemid 44148078)
29. F.A. Syed, U.I. Modder, D.G. Fraser, T.C. Spelsberg, C.J. Rosen, and A. Krust Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways J Bone Miner Res 20 2005 1992 2001 (Pubitemid 41532785)
30. F. Syed, and S. Khosla Mechanisms of sex steroid effects on bone Biochem Biophys Res Commun 328 2005 688 696 (Pubitemid 40214350)
31. S.A. Krum Direct transcriptional targets of sex steroid hormones in bone J Cell Biochem 112 2011 401 408
32. S. Safe, and K. Kim Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways J Mol Endocrinol 41 2008 263 275
33. S. Kousteni, T. Bellido, L.I. Plotkin, C.A. O'Brien, D.L. Bodenner, and L. Han Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity Cell 104 2001 719 730 (Pubitemid 32241022)
34. S.C. Manolagas, and S. Kousteni Perspective: nonreproductive sites of action of reproductive hormones Endocrinology 142 2001 2200 2204 (Pubitemid 32473072)
35. S. Kousteni, J.R. Chen, T. Bellido, L. Han, A.A. Ali, and C.A. O'Brien Reversal of bone loss in mice by nongenotropic signaling of sex steroids Science 298 2002 843 846 (Pubitemid 35231540)
36. S.C. Manolagas, S. Kousteni, and R.L. Jilka Sex steroids and bone Recent Prog Horm Res 57 2002 385 409
37. S. Kousteni, L. Han, J.R. Chen, M. Almeida, L.I. Plotkin, and T. Bellido Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids J Clin Invest 111 2003 1651 1664 (Pubitemid 38057747)
38. S.C. Manolagas, S. Kousteni, J.R. Chen, M. Schuller, L. Plotkin, and T. Bellido Kinase-mediated transcription, activators of nongenotropic estrogen-like signaling (ANGELS), and osteoporosis: a different perspective on the HRT dilemma Kidney Int Suppl 2004 S41 S49
39. M. Almeida, L. Han, T. Bellido, S.C. Manolagas, and S. Kousteni Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT J Biol Chem 280 2005 41342 41351 (Pubitemid 41832191)
40. J.R. Chen, L.I. Plotkin, J.I. Aguirre, L. Han, R.L. Jilka, and S. Kousteni Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens J Biol Chem 280 2005 4632 4638 (Pubitemid 40288632)
41. L.I. Plotkin, J.I. Aguirre, S. Kousteni, S.C. Manolagas, and T. Bellido Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation J Biol Chem 280 2005 7317 7325 (Pubitemid 40341290)
42. A.M. Vertino, C.M. Bula, J.R. Chen, M. Almeida, L. Han, and T. Bellido Nongenotropic, anti-apoptotic signaling of 1alpha, 25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases J Biol Chem 280 2005 14130 14137 (Pubitemid 40517315)
43. M. Almeida, L. Han, C.A. O'Brien, S. Kousteni, and S.C. Manolagas Classical genotropic versus kinase-initiated regulation of gene transcription by the estrogen receptor alpha Endocrinology 147 2006 1986 1996
44. S.C. Manolagas, R.L. Jilka, S. Kousteni, T. Bellido, R.S. Weinstein, and C.A. O'Brien Response to Windahl et al J Clin Invest 116 2006 2834
45. M. Almeida, L. Han, M. Martin-Millan, L.I. Plotkin, S.A. Stewart, and P.K. Roberson Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids J Biol Chem 282 2007 27285 27297 (Pubitemid 47501960)
46. S. Kousteni, M. Almeida, L. Han, T. Bellido, R.L. Jilka, and S.C. Manolagas Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor Mol Cell Biol 27 2007 1516 1530 (Pubitemid 46239831)
47. C.M. Klinge, K.A. Riggs, N.S. Wickramasinghe, C.G. Emberts, D.B. McConda, and P.N. Barry Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription Mol Cell Endocrinol 323 2010 268 276
48. H. Ishii, M. Kobayashi, and Y. Sakuma Alternative promoter usage and alternative splicing of the rat estrogen receptor alpha gene generate numerous mRNA variants with distinct 5′-ends J Steroid Biochem Mol Biol 118 2010 59 69
49. K.H. Kim, and J.R. Bender Membrane-initiated actions of estrogen on the endothelium Mol Cell Endocrinol 308 2009 3 8
50. K.H. Kim, K. Moriarty, and J.R. Bender Vascular cell signaling by membrane estrogen receptors Steroids 73 2008 864 869
51. Kim KH, Bender JR. Rapid, estrogen receptor-mediated signaling: why is the endothelium so special? Sci STKE 2005:pe28.
52. S. Denger, G. Reid, M. Kos, G. Flouriot, D. Parsch, and H. Brand ERalpha gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins Mol Endocrinol 15 2001 2064 2077 (Pubitemid 33141127)
53. A. Billon-Gales, C. Fontaine, C. Filipe, V. Douin-Echinard, M.J. Fouque, and G. Flouriot The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol Proc Natl Acad Sci USA 106 2009 2053 2058
54. G. Flouriot, H. Brand, S. Denger, R. Metivier, M. Kos, and G. Reid Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1 EMBO J 19 2000 4688 4700
55. J. Ford, A. Hajibeigi, M. Long, L. Hahner, C. Gore, and J.T. Hsieh GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice J Bone Miner Res 26 2011 298 307
56. S.H. Windahl, N. Andersson, A.S. Chagin, U.E. Martensson, H. Carlsten, and B. Olde The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice Am J Physiol Endocrinol Metab 296 2009 E490 E496
57. T.J. Heino, A.S. Chagin, and L. Savendahl The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone J Endocrinol 197 2008 R1 R6
58. E.R. Prossnitz, J.B. Arterburn, and L.A. Sklar GPR30: a G protein-coupled receptor for estrogen Mol Cell Endocrinol 265-266 2007 138 142 (Pubitemid 46273957)
59. A.S. Chagin, and L. Savendahl GPR30 estrogen receptor expression in the growth plate declines as puberty progresses J Clin Endocrinol Metab 92 2007 4873 4877 (Pubitemid 350223471)
60. G. Langer, B. Bader, L. Meoli, J. Isensee, M. Delbeck, and P.R. Noppinger A critical review of fundamental controversies in the field of GPR30 research Steroids 75 2010 603 610
61. L.J. Eichner, and V. Giguere Estrogen related receptors (ERRs): a new dawn in transcriptional control of mitochondrial gene networks Mitochondrion 11 2011 544 552
62. L. Gennari, V. De Paola, D. Merlotti, G. Martini, and R. Nuti Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review Expert Opin Pharmacother 8 2007 537 553 (Pubitemid 46547009)
63. S. Khosla Update on estrogens and the skeleton J Clin Endocrinol Metab 95 2010 3569 3577
64. E.P. Smith, B. Specker, B.E. Bachrach, K.S. Kimbro, X.J. Li, and M.F. Young Impact on bone of an estrogen receptor-alpha gene loss of function mutation J Clin Endocrinol Metab 93 2008 3088 3096
65. E.P. Smith, J. Boyd, G.R. Frank, H. Takahashi, R.M. Cohen, and B. Specker Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man N Engl J Med 331 1994 1056 1061 (Pubitemid 24317698)
66. R. Nuti, G. Martini, D. Merlotti, V. De Paola, F. Valleggi, and L. Gennari Bone metabolism in men: role of aromatase activity J Endocrinol Invest 30 2007 18 23
67. E.R. Simpson, C. Clyne, G. Rubin, W.C. Boon, K. Robertson, and K. Britt Aromatase - a brief overview Annu Rev Physiol 64 2002 93 127 (Pubitemid 34259227)
68. J.P. Bilezikian, A. Morishima, J. Bell, and M.M. Grumbach Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency N Engl J Med 339 1998 599 603 (Pubitemid 28385657)
69. C. Carani, K. Qin, M. Simoni, M. Faustini-Fustini, S. Serpente, and J. Boyd Effect of testosterone and estradiol in a man with aromatase deficiency N Engl J Med 337 1997 91 95 (Pubitemid 27284394)
70. V. Rochira, M. Faustini-Fustini, A. Balestrieri, and C. Carani Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters J Clin Endocrinol Metab 85 2000 1841 1845 (Pubitemid 32269286)
71. C. Carani, V. Rochira, M. Faustini-Fustini, A. Balestrieri, and A.R. Granata Role of oestrogen in male sexual behaviour: insights from the natural model of aromatase deficiency Clin Endocrinol (Oxf) 51 1999 517 524 (Pubitemid 29513321)
72. L. Vico, and J.M. Vanacker Sex hormones and their receptors in bone homeostasis: insights from genetically modified mouse models Osteoporos Int 21 2010 365 372
73. F.A. Syed, D.G. Fraser, D.G. Monroe, and S. Khosla Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor alpha on bone Bone 49 2011 208 216
74. A.S. Chagin, and L. Savendahl Oestrogen receptors and linear bone growth Acta Paediatr 96 2007 1275 1279 (Pubitemid 47300692)
75. J.F. Couse, and K.S. Korach Estrogen receptor null mice. what have we learned and where will they lead us? Endocr Rev 20 1999 358 417 (Pubitemid 30654784)
76. N.M. Teplyuk, M. Galindo, V.I. Teplyuk, J. Pratap, D.W. Young, and D. Lapointe Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors J Biol Chem 283 2008 27585 27597
77. J. Pratap, M. Galindo, S.K. Zaidi, D. Vradii, B.M. Bhat, and J.A. Robinson Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts Cancer Res 63 2003 5357 5362 (Pubitemid 37139851)
78. I.A. San Martin, N. Varela, M. Gaete, K. Villegas, M. Osorio, and J.C. Tapia Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells J Cell Physiol 221 2009 560 571
79. M. Centrella, S. Casinghino, and T.L. McCarthy Differential actions of prostaglandins in separate cell populations from fetal rat bone Endocrinology 135 1994 1611 1620 (Pubitemid 24307541)
80. T.L. McCarthy, C. Ji, H. Shu, S. Casinghino, K. Crothers, and P. Rotwein 17Beta-estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures J Biol Chem 272 1997 18132 18139 (Pubitemid 27306398)
81. U.E. Martensson, S.A. Salehi, S. Windahl, M.F. Gomez, K. Sward, and J. Daszkiewicz-Nilsson Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice Endocrinology 150 2009 687 698
82. M. Jakacka, M. Ito, F. Martinson, T. Ishikawa, E.J. Lee, and J.L. Jameson An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo Mol Endocrinol 16 2002 2188 2201 (Pubitemid 35155533)
83. M.A. McDevitt, C. Glidewell-Kenney, M.A. Jimenez, P.C. Ahearn, J. Weiss, J.L. Jameson, and J.E. Levine New insights into the classical and non-classical actions of estrogen: evidence from estrogen receptor knock-out and knock-in mice Mol Cell Endocrinol 290 2008 24 30
84. C. Glidewell-Kenney, L.A. Hurley, L. Pfaff, J. Weiss, J.E. Levine, and J.L. Jameson Nonclassical estrogen receptor alpha signaling mediates negative feedback in the female mouse reproductive axis Proc Natl Acad Sci USA 104 2007 8173 8177 (Pubitemid 47185894)
85. M.A. McDevitt, C. Glidewell-Kenney, J. Weiss, P. Chambon, J.L. Jameson, and J.E. Levine Estrogen response element-independent estrogen receptor (ER)-alpha signaling does not rescue sexual behavior but restores normal testosterone secretion in male ERalpha knockout mice Endocrinology 148 2007 5288 5294 (Pubitemid 350012644)
86. C. Glidewell-Kenney, J. Weiss, L.A. Hurley, J.E. Levine, and J.L. Jameson Estrogen receptor alpha signaling pathways differentially regulate gonadotropin subunit gene expression and serum follicle-stimulating hormone in the female mouse Endocrinology 149 2008 4168 4176
87. M. Centrella, S. Christakos, and T.L. McCarthy Skeletal hormones and the C/EBP and Runx transcription factors: interactions that integrate and redefine gene expression Gene 342 2004 13 24 (Pubitemid 39457172)
88. T.L. McCarthy, M.E. Clough, C.M. Gundberg, and M. Centrella Expression of an estrogen receptor agonist in differentiating osteoblast cultures Proc Natl Acad Sci USA 105 2008 7022 7027 (Pubitemid 351754523)
89. T.L. McCarthy, and M. Centrella Regulation of IGF activity in bone Adv Exp Med Biol 343 1993 407 414 (Pubitemid 24059308)
90. T.L. McCarthy, and M. Centrella Local IGF-I expression and bone formation Growth Horm IGF Res 11 2001 213 219 (Pubitemid 33072260)
91. F. Sato, Y. Ouchi, A. Masuyama, T. Nakamura, T. Hosoi, Y. Okamoto, N. Sasaki, M. Shiraki, and H. Orimo Effects of estrogen replacement on insulin-like growth factor I concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophorectomized rats Calcif Tissue Int 53 1993 111 116 (Pubitemid 23215385)
92. D.N. Kalu, B.H. Arjmandi, C.C. Liu, M.A. Salih, and R.S. Birnbaum Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 Bone Miner 25 1994 135 148
93. M.E. Wilson Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I J Clin Endocrinol Metab 83 1998 2018 2028 (Pubitemid 28496331)
94. D.A. Shewmon, J.L. Stock, C.J. Rosen, K.M. Heiniluoma, M.M. Hogue, and A. Morrison Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women Arterioscler Thromb 14 1994 1586 1593
95. R. Cozzi, R. Attanasio, G. Oppizzi, P. Orlandi, A. Giustina, and S. Lodrini Effects of tamoxifen on GH and IGF-I levels in acromegaly J Endocrinol Invest 20 1997 445 451 (Pubitemid 27483069)
96. S.M. Corsello, C.A. Rota, P. Putignano, S. Della Casa, A. Barnabei, and M.G. Migneco Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer Eur J Endocrinol 139 1998 309 313 (Pubitemid 28430543)
97. A. Balogh, E. Kauf, R. Vollanth, G. Graser, G. Klinger, and M. Oettel Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH) Contraception 62 2000 259 269 (Pubitemid 32126660)
98. R.T. Turner, and T.C. Spelsberg Correlation between mRNA levels for bone cell proteins and bone formation in long bones of maturing rats Am J Physiol 261 1991 E348 E353
99. R.T. Turner, P. Backup, P.J. Sherman, E. Hill, G.L. Evans, and T.C. Spelsberg Mechanism of action of estrogen on intramembranous bone formation: regulation of osteoblast differentiation and activity Endocrinology 131 1992 883 889
100. K.C. Westerlind, G.K. Wakley, G.L. Evans, and R.T. Turner Estrogen does not increase bone formation in growing rats Endocrinology 133 1993 2924 2934 (Pubitemid 24000756)
101. R.T. Turner, B.L. Riggs, and T.C. Spelsberg Skeletal effects of estrogen Endocr Rev 15 1994 275 300 (Pubitemid 24180788)
102. M.A. Salih, C.C. Liu, B.H. Arjmandi, and D.N. Kalu Estrogen modulates the mRNA levels for cancellous bone protein of ovariectomized rats Bone Miner 23 1993 285 299
103. K.E. Govoni, J.E. Wergedal, R.B. Chadwick, A.K. Srivastava, and S. Mohan Prepubertal OVX increases IGF-I expression and bone accretion in C57BL/6J mice Am J Physiol Endocrinol Metab 295 2008 E1172 E1180
104. L.J. Murphy, and H.G. Friesen Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat Endocrinology 122 1988 325 332 (Pubitemid 18027619)
105. D.L. Kleinberg, T.L. Wood, P.A. Furth, and A.V. Lee Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions Endocr Rev 30 2009 51 74
106. M.C. Boruban, K. Altundag, G.S. Kilic, and J. Blankstein From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures Eur J Cancer Prev 17 2008 133 138 (Pubitemid 351301624)
107. B.A. Stoll Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications Ann Oncol 13 2002 191 196 (Pubitemid 34704969)
108. Y. Umayahara, R. Kawamori, H. Watada, E. Imano, N. Iwama, and T. Morishima Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer J Biol Chem 269 1994 16433 16442 (Pubitemid 24209344)
109. M. Ernst, J.K. Heath, and G.A. Rodan Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones Endocrinology 125 1989 825 833 (Pubitemid 19205075)
110. M. Ernst, and G.A. Rodan Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control Mol Endocrinol 5 1991 1081 1089
111. T.L. McCarthy, M. Centrella, and E. Canalis Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone Endocrinology 124 1989 1247 1253 (Pubitemid 19082692)
112. T.L. McCarthy, M. Centrella, and E. Canalis Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures J Biol Chem 265 1990 15353 15356
113. T.L. McCarthy, M. Centrella, L.G. Raisz, and E. Canalis Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone Endocrinology 128 1991 2895 2900
114. D.P. Bichell, P. Rotwein, and T.L. McCarthy Prostaglandin E2 rapidly stimulates insulin-like growth factor-I gene expression in primary rat osteoblast cultures: evidence for transcriptional control Endocrinology 133 1993 1020 1028 (Pubitemid 23267750)
115. M.J. Thomas, Y. Umayahara, H. Shu, M. Centrella, P. Rotwein, and T.L. McCarthy Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E2 in osteoblasts J Biol Chem 271 1996 21835 21841 (Pubitemid 26303803)
116. D.D. Bikle, T. Sakata, C. Leary, H. Elalieh, D. Ginzinger, and C.J. Rosen Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone J Bone Miner Res 17 2002 1570 1578
117. Y. Wang, S. Nishida, B.M. Boudignon, A. Burghardt, H.Z. Elalieh, and M.M. Hamilton IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone J Bone Miner Res 22 2007 1329 1337 (Pubitemid 351339678)
118. N. Miyakoshi, Y. Kasukawa, T.A. Linkhart, D.J. Baylink, and S. Mohan Evidence that anabolic effects of PTH on bone require IGF-I in growing mice Endocrinology 142 2001 4349 4356 (Pubitemid 32907063)
119. W. Chang, M. Parra, M. Centrella, and T.L. McCarthy Interactions between CCAAT enhancer binding protein delta and estrogen receptor alpha control insulin-like growth factor I (igf1) and estrogen receptor-dependent gene expression in osteoblasts Gene 345 2005 225 235 (Pubitemid 40228830)
120. M. Kassem, S.A. Harris, T.C. Spelsberg, and B.L. Riggs Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors J Bone Miner Res 11 1996 193 199 (Pubitemid 26054176)
121. J.P. Bonjour, G. Theintz, B. Buchs, D. Slosman, and R. Rizzoli Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence J Clin Endocrinol Metab 73 1991 555 563 (Pubitemid 21921908)
122. T.L. McCarthy, M.J. Thomas, M. Centrella, and P. Rotwein Regulation of insulin-like growth factor I transcription by cyclic adenosine 3′,5′-monophosphate (cAMP) in fetal rat bone cells through an element within exon 1: protein kinase A-dependent control without a consensus AMP response element Endocrinology 136 1995 3901 3908
123. Y. Umayahara, J. Billiard, C. Ji, M. Centrella, T.L. McCarthy, and P. Rotwein CCAAT/enhancer-binding protein delta is a critical regulator of insulin-like growth factor-I gene transcription in osteoblasts J Biol Chem 274 1999 10609 10617
124. Y. Umayahara, C. Ji, M. Centrella, P. Rotwein, and T.L. McCarthy CCAAT/enhancer-binding protein delta activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone J Biol Chem 272 1997 31793 31800 (Pubitemid 28013330)
125. T.L. McCarthy, C. Ji, Y. Chen, K. Kim, and M. Centrella Time- and dose-related interactions between glucocorticoid and cyclic adenosine 3′,5′-monophosphate on CCAAT/enhancer-binding protein-dependent insulin-like growth factor I expression by osteoblasts Endocrinology 141 2000 127 137 (Pubitemid 32260351)
126. J. Billiard, Y. Umayahara, K. Wiren, M. Centrella, T.L. McCarthy, and P. Rotwein Regulated nuclear-cytoplasmic localization of CCAAT/enhancer-binding protein delta in osteoblasts J Biol Chem 276 2001 15354 15361
127. V. Poli, R. Balena, E. Fattori, A. Markatos, M. Yamamoto, and H. Tanaka Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion EMBO J 13 1994 1189 1196 (Pubitemid 24074725)
128. A. Ray, K.E. Prefontaine, and P. Ray Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor J Biol Chem 269 1994 12940 12946 (Pubitemid 24202095)
129. P. Ray, S.K. Ghosh, D.H. Zhang, and A. Ray Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor FEBS Lett 409 1997 79 85 (Pubitemid 27248571)
130. E.M. Greenfield, Y. Bi, and A. Miyauchi Regulation of osteoclast activity Life Sci 65 1999 1087 1102 (Pubitemid 29416740)
131. B.L. Riggs The mechanisms of estrogen regulation of bone resorption J Clin Invest 106 2000 1203 1204
132. S.A. Doggrell Present and future pharmacotherapy for osteoporosis Drugs Today (Barc) 39 2003 633 657 (Pubitemid 37295517)
133. M.C. Bezerra, J.F. Carvalho, A.S. Prokopowitsch, and R.M. Pereira RANK, RANKL and osteoprotegerin in arthritic bone loss Braz J Med Biol Res 38 2005 161 170 (Pubitemid 40378401)
134. H.C. Blair, L.J. Robinson, and M. Zaidi Osteoclast signalling pathways Biochem Biophys Res Commun 328 2005 728 738 (Pubitemid 40208310)
135. M. Centrella, and E. Canalis Transforming and nontransforming growth factors are present in medium conditioned by fetal rat calvariae Proc Natl Acad Sci USA 82 1985 7335 7339 (Pubitemid 16193737)
136. M. Centrella, and E. Canalis Local regulators of skeletal growth: a perspective Endocr Rev 6 1985 544 551
137. Y. Shi, and J. Massague Mechanisms of TGF-beta signaling from cell membrane to the nucleus Cell 113 2003 685 700 (Pubitemid 36724933)
138. E. Piek, C.H. Heldin, and P. ten Dijke Specificity, diversity, and regulation in TGF-beta superfamily signaling FASEB J 13 1999 2105 2124
139. P. ten Dijke, K.K. Iwata, C. Goddard, C. Pieler, E. Canalis, and T.L. McCarthy Recombinant transforming growth factor type beta 3: biological activities and receptor-binding properties in isolated bone cells Mol Cell Biol 10 1990 4473 4479
140. M. Centrella, T.L. McCarthy, and E. Canalis Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone J Biol Chem 262 1987 2869 2874
141. M. Centrella, T.L. McCarthy, and E. Canalis Mitogenesis in fetal rat bone cells simultaneously exposed to type beta transforming growth factor and other growth regulators FASEB J 1 1987 312 317 (Pubitemid 18034355)
142. M. Centrella, T.L. McCarthy, and E. Canalis Skeletal tissue and transforming growth factor beta FASEB J 2 1988 3066 3073 (Pubitemid 19021168)
143. M. Centrella, S. Casinghino, R. Ignotz, and T.L. McCarthy Multiple regulatory effects by transforming growth factor-beta on type I collagen levels in osteoblast-enriched cultures from fetal rat bone Endocrinology 131 1992 2863 2872
144. M. Centrella, M.C. Horowitz, J.M. Wozney, and T.L. McCarthy Transforming growth factor-beta gene family members and bone Endocr Rev 15 1994 27 39
145. M. Centrella, S. Casinghino, J. Kim, T. Pham, V. Rosen, and J. Wozney Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype Mol Cell Biol 15 1995 3273 3281
146. A. Erlebacher, and R. Derynck Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype J Cell Biol 132 1996 195 210
147. A. Erlebacher, E.H. Filvaroff, J.Q. Ye, and R. Derynck Osteoblastic responses to TGF-beta during bone remodeling Mol Biol Cell 9 1998 1903 1918 (Pubitemid 28337531)
148. K.K. Kim, C. Ji, W. Chang, R.G. Wells, C.M. Gundberg, T.L. McCarthy, and M. Centrella Repetitive exposure to TGF-beta suppresses TGF-beta type I receptor expression by differentiated osteoblasts Gene 379 2006 175 184 (Pubitemid 44247339)
149. M. Centrella, C. Ji, S. Casinghino, and T.L. McCarthy Rapid flux in transforming growth factor-beta receptors on bone cells J Biol Chem 271 1996 18616 18622 (Pubitemid 26322725)
150. M. Centrella, T.L. McCarthy, and E. Canalis Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone Proc Natl Acad Sci USA 85 1988 5889 5893
151. M. Centrella, E. Canalis, T.L. McCarthy, A.F. Stewart, J.J. Orloff, and K.L. Insogna Parathyroid hormone-related protein modulates the effect of transforming growth factor-beta on deoxyribonucleic acid and collagen synthesis in fetal rat bone cells Endocrinology 125 1989 199 208 (Pubitemid 19182660)
152. M. Centrella, T.L. McCarthy, and E. Canalis Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone Mol Cell Biol 11 1991 4490 4496 (Pubitemid 21895845)
153. M. Centrella, V. Rosen, J.M. Wozney, S.R. Casinghino, and T.L. McCarthy Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures J Cell Biochem 67 1997 528 540 (Pubitemid 27508405)
154. C. Ji, Y. Chen, T.L. McCarthy, and M. Centrella Cloning the promoter for transforming growth factor-beta type III receptor. Basal and conditional expression in fetal rat osteoblasts J Biol Chem 274 1999 30487 30494
155. T.L. McCarthy, W.Z. Chang, Y. Liu, and M. Centrella Runx2 integrates estrogen activity in osteoblasts J Biol Chem 278 2003 43121 43129 (Pubitemid 37345930)
156. W. Chang, M. Parra, C. Ji, Y. Liu, O. Eickelberg, and T.L. McCarthy Transcriptional and post-transcriptional regulation of transforming growth factor beta type II receptor expression in osteoblasts Gene 299 2002 65 77 (Pubitemid 35379828)
157. T.L. McCarthy, and M. Centrella Novel links among Wnt and TGF-beta signaling and Runx2 Mol Endocrinol 24 2010 587 597
158. T.L. McCarthy, T.H. Pham, B.I. Knoll, and M. Centrella Prostaglandin E2 increases transforming growth factor-beta type III receptor expression through CCAAT enhancer-binding protein delta in osteoblasts Mol Endocrinol 21 2007 2713 2724 (Pubitemid 350035153)
159. D.J. Chang, C. Ji, K.K. Kim, S. Casinghino, T.L. McCarthy, and M. Centrella Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid J Biol Chem 273 1998 4892 4896 (Pubitemid 28108639)
160. C. Ji, S. Casinghino, D.J. Chang, Y. Chen, A. Javed, and Y. Ito CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation J Cell Biochem 69 1998 353 363 (Pubitemid 28227711)
161. C. Ji, S. Casinghino, T.L. McCarthy, and M. Centrella Cloning, characterization, and expression of the transforming growth factor-beta type I receptor promoter in fetal rat bone cells J Cell Biochem 63 1996 478 490 (Pubitemid 27009267)
162. C. Ji, S. Casinghino, T.L. McCarthy, and M. Centrella Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-beta type I receptor J Biol Chem 272 1997 21260 21267 (Pubitemid 27373991)
163. C. Ji, O. Eickelberg, T.L. McCarthy, and M. Centrella Control and counter-control of TGF-beta activity through FAST and Runx (CBFa) transcriptional elements in osteoblasts Endocrinology 142 2001 3873 3879 (Pubitemid 32802659)
164. M. Prince, C. Banerjee, A. Javed, J. Green, J.B. Lian, and G.S. Stein Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts J Cell Biochem 80 2001 424 440 (Pubitemid 32141498)
165. A. Taranta, M. Brama, A. Teti, V. De luca, R. Scandurra, and G. Spera The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro Bone 30 2002 368 376 (Pubitemid 34150159)
166. T.L. McCarthy, R.B. Hochberg, D.C. Labaree, and M. Centrella 3-Ketosteroid reductase activity and expression by fetal rat osteoblasts J Biol Chem 282 2007 34003 34012 (Pubitemid 350159449)
167. K.V. Juttner, and M.J. Perry High-dose estrogen-induced osteogenesis is decreased in aged RUNX2(+/-) mice Bone 41 2007 25 32 (Pubitemid 46891897)
168. O. Khalid, S.K. Baniwal, D.J. Purcell, N. Leclerc, Y. Gabet, and M.R. Stallcup Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer Endocrinology 149 2008 5984 5995
169. B.T. MacDonald, K. Tamai, and X. He Wnt/beta-catenin signaling: components, mechanisms, and diseases Dev Cell 17 2009 9 26
170. K.M. Cadigan Wnt-beta-catenin signaling Curr Biol 18 2008 R943 R947
171. K.M. Cadigan Wnt/beta-catenin signaling: turning the switch Dev Cell 14 2008 322 323
172. L. Arce, N.N. Yokoyama, and M.L. Waterman Diversity of LEF/TCF action in development and disease Oncogene 25 2006 7492 7504 (Pubitemid 44885748)
173. Y. Chen, H.C. Whetstone, A. Youn, P. Nadesan, E.C. Chow, and A.C. Lin Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation J Biol Chem 282 2007 526 533 (Pubitemid 47076655)
174. N.H. Kulkarni, D.L. Halladay, R.R. Miles, L.M. Gilbert, C.A. Frolik, and R.J. Galvin Effects of parathyroid hormone on Wnt signaling pathway in bone J Cell Biochem 95 2005 1178 1190 (Pubitemid 41420125)
175. T. Tobimatsu, H. Kaji, H. Sowa, J. Naito, L. Canaff, and G.N. Hendy Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells Endocrinology 147 2006 2583 2590
176. M.K. Bergenstock, and N.C. Partridge Parathyroid hormone stimulation of noncanonical Wnt signaling in bone Ann NY Acad Sci 1116 2007 354 359 (Pubitemid 350274334)
177. T. Gaur, C.J. Lengner, H. Hovhannisyan, R.A. Bhat, P.V. Bodine, and B.S. Komm Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression J Biol Chem 280 2005 33132 33140 (Pubitemid 41397109)
178. C.N. Bennett, K.A. Longo, W.S. Wright, L.J. Suva, T.F. Lane, and K.D. Hankenson Regulation of osteoblastogenesis and bone mass by Wnt10b Proc Natl Acad Sci USA 102 2005 3324 3329 (Pubitemid 40328044)
179. Y. Zhang, Y. Wang, X. Li, J. Zhang, J. Mao, and Z. Li The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd Mol Cell Biol 24 2004 4677 4684 (Pubitemid 38668035)
180. M. Kato, M.S. Patel, R. Levasseur, I. Lobov, B.H. Chang, and D.A. Glass 2nd Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor J Cell Biol 157 2002 303 314 (Pubitemid 34839826)
181. B.H. Hoang, T. Kubo, J.H. Healey, R. Sowers, B. Mazza, and R. Yang Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma Int J Cancer 109 2004 106 111 (Pubitemid 38160669)
182. I. Takada, M. Mihara, M. Suzawa, F. Ohtake, S. Kobayashi, and M. Igarashi A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation Nat Cell Biol 9 2007 1273 1285 (Pubitemid 350042359)
183. D.A. Glass 2nd, P. Bialek, J.D. Ahn, M. Starbuck, M.S. Patel, and H. Clevers Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation Dev Cell 8 2005 751 764 (Pubitemid 40585297)
184. Y. Gong, R.B. Slee, N. Fukai, G. Rawadi, S. Roman-Roman, and A.M. Reginato LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development Cell 107 2001 513 523 (Pubitemid 33152786)
185. V.K. Yadav, J.H. Ryu, N. Suda, K.F. Tanaka, J.A. Gingrich, and G. Schutz Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum Cell 135 2008 825 837
186. S.L. Holmen, T.A. Giambernardi, C.R. Zylstra, B.D. Buckner-Berghuis, J.H. Resau, and J.F. Hess Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6 J Bone Miner Res 19 2004 2033 2040 (Pubitemid 41103418)
187. A. Mani, J. Radhakrishnan, H. Wang, A. Mani, M.A. Mani, and C. Nelson-Williams LRP6 mutation in a family with early coronary disease and metabolic risk factors Science 315 2007 1278 1282 (Pubitemid 46364265)
188. B.L. Vaes, K.J. Dechering, A. Feijen, J.M. Hendriks, C. Lefevre, and C.L. Mummery Comprehensive microarray analysis of bone morphogenetic protein 2-induced osteoblast differentiation resulting in the identification of novel markers for bone development J Bone Miner Res 17 2002 2106 2118 (Pubitemid 35416746)
189. B.L. Vaes, K.J. Dechering, E.P. van Someren, J.M. Hendriks, C.J. van de Ven, and A. Feijen Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts Bone 36 2005 803 811 (Pubitemid 40616015)
190. R.L. van Bezooijen, B.A. Roelen, A. Visser, L. van der Wee-Pals, E. de Wilt, and M. Karperien Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist J Exp Med 199 2004 805 814 (Pubitemid 38375200)
191. T.L. McCarthy, W.-Z. Chang, Y. Liu, and M. Centrella Runx2 integrates estrogen activity in osteoblasts J Biol Chem 278 2003 43121 43129 (Pubitemid 37345930)
192. O. Khalid, S.K. Baniwal, D.J. Purcell, N. Leclerc, Y. Gabet, and M.R. Stallcup Modulation of Runx2 activity by estrogen receptor {alpha}: implications for osteoporosis and breast cancer Endocrinology 149 2008 5984 5995
193. M. El-Tanani, D.G. Fernig, R. Barraclough, C. Green, and P. Rudland Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors J Biol Chem 276 2001 41675 41682
194. A.P. Kouzmenko, K. Takeyama, S. Ito, T. Furutani, S. Sawatsubashi, and A. Maki Wnt/beta-catenin and estrogen signaling converge in vivo J Biol Chem 279 2004 40255 40258 (Pubitemid 39287607)
195. O. Varea, M.A. Arevalo, J.J. Garrido, L.M. Garcia-Segura, F. Wandosell, and P. Mendez Interaction of estrogen receptors with insulin-like growth factor-I and Wnt signaling in the nervous system Steroids 75 2010 565 569
196. A. Sunters, V.J. Armstrong, G. Zaman, R.M. Kypta, Y. Kawano, and L.E. Lanyon Mechano-transduction in osteoblastic cells involves strain-regulated estrogen receptor alpha-mediated control of insulin-like growth factor (IGF) I receptor sensitivity to Ambient IGF, leading to phosphatidylinositol 3-kinase/AKT-dependent Wnt/LRP5 receptor-independent activation of beta-catenin signaling J Biol Chem 285 2010 8743 8758
197. T.L. McCarthy, C.B. Kallen, and M. Centrella Beta-catenin independent cross-control between the estradiol and Wnt pathways in osteoblasts Gene 479 2011 16 28
198. H. Nawata, S. Tanaka, S. Tanaka, R. Takayanagi, Y. Sakai, and T. Yanase Aromatase in bone cell: association with osteoporosis in postmenopausal women J Steroid Biochem Mol Biol 53 1995 165 174
199. S. Tanaka, M. Haji, R. Takayanagi, S. Tanaka, Y. Sugioka, and H. Nawata 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts Endocrinology 137 1996 1860 1869
200. H. Sasano, M. Uzuki, T. Sawai, H. Nagura, G. Matsunaga, and O. Kashimoto Aromatase in human bone tissue J Bone Miner Res 12 1997 1416 1423 (Pubitemid 27375384)
201. J.M. Janssen, R. Bland, M. Hewison, M.W. Coughtrie, S. Sharp, and J. Arts Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function J Cell Biochem 75 1999 528 537 (Pubitemid 29521659)
202. M. Watanabe, S. Ohno, and S. Nakajin Forskolin and dexamethasone synergistically induce aromatase (CYP19) expression in the human osteoblastic cell line SV-HFO Eur J Endocrinol 152 2005 619 624 (Pubitemid 40575808)
203. J.L. Hernandez, C.M. Garces, M. Sumillera, E.V. Fernandez-Aldasoro, C. Garcia-Ibarbia, and J.A. Ortiz-Gomez Aromatase expression in osteoarthritic and osteoporotic bone Arthritis Rheum 58 2008 1696 1700 (Pubitemid 351847522)
204. M. Watanabe, M. Noda, and S. Nakajin Aromatase expression in a human osteoblastic cell line increases in response to prostaglandin E(2) in a dexamethasone-dependent fashion Steroids 72 2007 686 692 (Pubitemid 47126563)
205. E. Damien, J.S. Price, and L.E. Lanyon Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females J Bone Miner Res 15 2000 2169 2177
206. A. Purohit, A.M. Flanagan, and M.J. Reed Estrogen synthesis by osteoblast cell lines Endocrinology 131 1992 2027 2029
207. J.H. Jeong, Y.K. Jung, H.J. Kim, J.S. Jin, H.N. Kim, and S.M. Kang The gene for aromatase, a rate-limiting enzyme for local estrogen biosynthesis, is a downstream target gene of Runx2 in skeletal tissues Mol Cell Biol 30 2010 2365 2375
208. T.M. Penning Molecular endocrinology of hydroxysteroid dehydrogenases Endocr Rev 18 1997 281 305 (Pubitemid 27246879)
209. T.M. Penning Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action Hum Reprod Update 9 2003 193 205 (Pubitemid 36827058)
210. T.M. Penning, M.E. Burczynski, J.M. Jez, C.F. Hung, H.K. Lin, and H. Ma Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones Biochem J 351 2000 67 77
211. T.M. Penning, and J.E. Drury Human aldo-keto reductases: function, gene regulation, and single nucleotide polymorphisms Arch Biochem Biophys 2007
212. T.M. Penning, Y. Jin, V.V. Heredia, and M. Lewis Structure-function relationships in 3alpha-hydroxysteroid dehydrogenases: a comparison of the rat and human isoforms J Steroid Biochem Mol Biol 85 2003 247 255 (Pubitemid 37011100)
213. T.M. Penning, Y. Jin, S. Steckelbroeck, T. Lanisnik Rizner, and M. Lewis Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins Mol Cell Endocrinol 215 2004 63 72 (Pubitemid 38337424)
214. M. Centrella, T.L. McCarthy, W.Z. Chang, D.C. Labaree, and R.B. Hochberg Estren (4-estren-3alpha,17beta-diol) is a prohormone that regulates both androgenic and estrogenic transcriptional effects through the androgen receptor Mol Endocrinol 18 2004 1120 1130 (Pubitemid 38591279)
215. Y. Jin, L. Duan, S.H. Lee, H.J. Kloosterboer, I.A. Blair, and T.M. Penning Human cytosolic hydroxysteroid dehydrogenases of the aldo-ketoreductase superfamily catalyze reduction of conjugated steroids: implications for phase I and phase II steroid hormone metabolism J Biol Chem 284 2009 10013 10022
216. Y. Jin, and T.M. Penning Molecular docking simulations of steroid substrates into human cytosolic hydroxysteroid dehydrogenases (AKR1C1 and AKR1C2): insights into positional and stereochemical preferences Steroids 71 2006 380 391 (Pubitemid 43675668)
217. T.M. Penning, S.H. Lee, Y. Jin, A. Gutierrez, and I.A. Blair Liquid chromatography-mass spectrometry (LC-MS) of steroid hormone metabolites and its applications J Steroid Biochem Mol Biol 121 2010 546 555
218. S. Steckelbroeck, Y. Jin, B. Oyesanmi, H.J. Kloosterboer, and T.M. Penning Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid Mol Pharmacol 66 2004 1702 1711 (Pubitemid 39571719)
219. S. Steckelbroeck, B. Oyesanmi, Y. Jin, S.H. Lee, H.J. Kloosterboer, and T.M. Penning Tibolone metabolism in human liver is catalyzed by 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily J Pharmacol Exp Ther 316 2006 1300 1309 (Pubitemid 43345306)
220. L.I. McKay, and J.A. Cidlowski Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism Mol Endocrinol 12 1998 45 56 (Pubitemid 28124778)
221. L.I. McKay, and J.A. Cidlowski Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways Endocr Rev 20 1999 435 459 (Pubitemid 30648895)
222. P. Dhawan, X. Peng, A.L. Sutton, P.N. MacDonald, C.M. Croniger, and C. Trautwein Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase Mol Cell Biol 25 2005 472 487 (Pubitemid 40039836)
223. Q. Shen, and S. Christakos The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin J Biol Chem 280 2005 40589 40598 (Pubitemid 41780549)
224. P.W. Hsiao, B.J. Deroo, and T.K. Archer Chromatin remodeling and tissue-selective responses of nuclear hormone receptors Biochem Cell Biol 80 2002 343 351 (Pubitemid 34748273)
225. M.T. Sutter-Dub Rapid non-genomic and genomic responses to progestogens, estrogens, and glucocorticoids in the endocrine pancreatic B cell, the adipocyte and other cell types Steroids 67 2002 77 93
226. T. Simoncini, and A.R. Genazzani Non-genomic actions of sex steroid hormones Eur J Endocrinol 148 2003 281 292 (Pubitemid 36410713)